The performance track record of emerging markets (EM) stocks over two decades highlights the need to stay allocated and ride inevitable market volatility, said EM equities specialist Sammy Suzuki.

The performance track record of emerging markets (EM) stocks over two decades highlights the need to stay allocated and ride inevitable market volatility, said EM equities specialist Sammy Suzuki.
Most healthcare investors focus on binary bets around clinical trials instead of buying profitable healthcare businesses, according to AllianceBernstein’s Vinay Thapar.
Brent Kao previously spent 14 years as head of Asia official institutions and consultant relations at BlackRock.
AllianceBernstein’s global head of investments tells FSA where the firm is focusing resources over the next twelve months.
As part of FSA’s head-to-head series, we compare the Federated Hermes Global Emerging Markets SMID Equity fund and the Invesco Emerging Markets ex-China fund.
Souheir Asba will oversee the firm’s investment-grade credit strategies.
Fidelity beaks into the top five for the first time in Broadridge’s China Power Ranking, a survey of the top performing asset managers in China.
This week FSA presents a quick comparison of two eurozone products: the AB Eurozone Equity Portfolio fund and the Invesco Euro Equity fund.
Aditya Monappa, explains why now is a good time to allocate to private credit and where the opportunities in private equity exist.
Liliana Castillo Dearth, who heads up the firm’s emerging market and Asia equities team, will be based in London.
Part of the Mark Allen Group.